Top Markets
Coin of the day
PLx Pharma Inc. PLx Pharma Inc.

PLx Pharma Inc.

PLXP
Pozycja w akcjach #41012
PLx Pharma Inc. is a U.S.-based entity leveraging its innovative drug delivery... PLx Pharma Inc. is a U.S.-based entity leveraging its innovative drug delivery platform technology, having successfully transitioned into the commercial stage. The company's primary offerings include Vazalore 325 mg, which is formulated for individuals facing vascular incidents like heart attacks and clot-induced strokes, as well as for the management of pain and inflammation. Additionally, they provide Vazalore 81 mg in the form of liquid-filled aspirin capsules. Looking ahead, their product development pipeline features PL1200 Ibuprofen 200 mg and PL1100 Ibuprofen 400 mg, both of which are in Phase I clinical trials for addressing pain, inflammation, and fever. PLx Pharma makes its products available to consumers through a variety of retail avenues, including pharmacies, major retailers, supermarkets, and online sales channels. Founded in 2002, PLx Pharma Inc. is headquartered in Sparta, New Jersey.
Cena akcji
$0.00575
Ostatnia synchronizacja: 2023-05-23
Kapitalizacja rynkowa
$51.30K
Zmiana (1 dzień)
-17.86%
Zmiana (1 rok)
0.00%
Kraj
US
Handel PLx Pharma Inc. (PLXP)

Kategoria

EPS dla PLx Pharma Inc. (PLXP)
EPS na dzień 2026 TTM: 0
Według najnowszych raportów finansowych i ceny akcji firmy PLx Pharma Inc., obecny EPS (TTM) wynosi 0. Na koniec roku 2026 firma miała EPS w wysokości 0, równa się do EPS z roku 2026, który wynosił 0.
Historia EPS dla PLx Pharma Inc. od 2026 do 2026
EPS na koniec każdego roku
Rok EPS Zmień
Za mało danych dla podanych dat.